Three deaths in China shake trust in the country's speedy clinical trial system
By Ryan Cross,
Endpoints News
| 08. 20. 2026
China’s cheap, fast and quiet system for testing cutting-edge medicines is facing scrutiny after the deaths of three people in investigator-initiated trials.
The studies, also known as IITs, allow experimental cell and gene therapies to be tested without oversight from China’s national drug regulators and have become the envy of many US biotech leaders. Now three groups vying to be the first to successfully pioneer a cure for autoimmune disease and new applications of CRISPR gene editing have seen their work lead to tragedy.
“I was sad but not at all surprised,” said Kiran Musunuru, a gene editing scientist at the University of Pennsylvania who knew early on about the two ill-fated CRISPR gene therapy trials — one for children with a neurological condition and the other for those with a fatal muscle disease. “I remember vividly thinking this isn’t going to end well. It had all the makings of a disaster.”
The deaths have become a flashpoint for several ongoing debates, including the transparency and trustworthiness of drug development in China and the wisdom of the country’s lenient IIT...
Related Articles
By Emma McDonald Kennedy
| 10.29.2026
At the beginning of Nathan Fielder and Lance Oppenheim’s blockbuster documentary You Can See Everything, Billy Evans (partner of Theranos founder and convicted fraudster Elizabeth Holmes), says that they decided to do the film for one purpose: “radical transparency.” As they work on “Theranos 2.0,” Evans and Holmes want to show the public that she has been misunderstood –– painted as a liar and a fraud in the public imagination (and the courts) despite, as she claims in the...
By Jan Grue, The Guardian | 10.27.2026
For a very long time, I dreamed of being cured. I was born in 1981. I learned to walk early enough, but I stumbled and fell more easily than other children. My parents began to worry that something was wrong...
By Gary Sernovitz, Bloomberg | 10.21.2026
Three years ago, at the age of 50, I found out I have dangerous genes. So in June, I went to Cambridge, Massachusetts, to see how they could be fixed. Among my 6 billion base pairs of DNA are two...
By Carl Zimmer, The New York Times | 10.20.2026
For the first time, scientists say they have used viruses designed by artificial intelligence to treat a human patient.
Researchers announced on Tuesday that they had administered the virus, known as a phage, to a patient suffering from a deadly...